drugset / Trial / NCT01046162

A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions

NCT01046162

RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to compare bioavailability between formulations of alprazolam in tablets to determine their bioequivalence in terms of rate and magnitude of absorption.

Timeline

Start
2010-07-15
Primary completion
2010-07-22
Completion
2010-07-22

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alprazolam Small molecule 2 mg

Indications

No indication recorded.